Svelte Medical Systems

company

About

Svelte Medical Systems is a healthcare company engaged in the design and development of highly deliverable balloon expandable stents.

  • 1 - 10

Details

Last Funding Type
Debt Financing
Last Funding Money Raised
$6M
Industries
Health Care,Medical,Medical Device
Founded date
Jan 1, 2007
Number Of Employee
1 - 10
Operating Status
Active

Svelte Medical Systems (Svelte) is a privately held company focused on delivering novel products in the $5 billion coronary stent market. Its mission is to address key clinical issues in the stent market by improving stent deliverability, reducing cost, and dramatically improving the safety of the device compared to current market products.

Svelte has developed the lowest profile and most deliverable balloon-expandable stent in the market, along with technology to create a non-thrombogenic, non-inflammatory Drug-Eluting Stent (DES).

Svelte was started by Robert Fischell, David Fischell, and Tim Fischell in 2007.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$6M
Svelte Medical Systems has raised a total of $6M in funding over 2 rounds. Their latest funding was raised on Nov 7, 2009 from a Debt Financing round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 7, 2009 Debt Financing $6M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Svelte Medical Systems is funded by 1 investors. Norwich Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Norwich Ventures Debt Financing